Binding and degradation of elastin by the staphylolytic enzyme lysostaphin

The International Journal of Biochemistry & Cell Biology - Tập 27 Số 2 - Trang 139-146 - 1995
Pyong Woo Park1, Robert M. Senior2, Gail L. Griffin2, Thomas J. Broekelmann2, M. Susan Mudd2, Robert P. Mecham1,2
1Department of Cell Biology and Physiology, Washington University School of Medicine, St. Louis, MO 63110 U.S.A.
2Respiratory and Critical Care Division, Department of Medicine, Jewish Hospital at Washington University School of Medicine, St Louis, MO 63110, U.S.A.

Tóm tắt

Từ khóa


Tài liệu tham khảo

Banda, 1981, Elastinolytic enzymes, 603

Bányai, 1991, Evidence for the involvement of type II domains in collagen binding by 72 kDa type IV procollagenase, FEBS Lett, 282, 23, 10.1016/0014-5793(91)80436-7

de Jonge, 1993, Altered muropeptide composition in Staphylococcus aureus strains with an inactivated femA locus, J. Bacteriol., 175, 2779, 10.1128/jb.175.9.2779-2782.1993

Heath, 1989, Plasmid-encoded lysostaphin endopeptidase resistance of Staphylococcus simulans biovar staphylolyticus, Biochem. biophys. Res. Commun., 160, 1106, 10.1016/S0006-291X(89)80117-2

Heinrich, 1987, The molecular organization of the lysostaphin gene and its sequences repeated in tandem, Molec. Gen. Genet., 209, 563, 10.1007/BF00331163

Iversen, 1973, Studies on lysostaphin, 38, 293

Jeng, 1994, Expression, purification, and characterization of a truncated form of mouse metalloelastase (MME), FASEB J., 8, A151

Langlois, 1990, Effect of BiTek agar on lysostaphin susceptibility of staphylococci, J. Clin. Microbiol., 28, 2568, 10.1128/JCM.28.11.2568-2569.1990

Maidhof, 1991, femA, which encodes a factor essential for expression of methicillin resistance, affects glycine content of peptidoglycan in methicillin-resistant and methicillin-susceptible Staphylococcus aureus strains, J. Bacteriol., 173, 3507, 10.1128/jb.173.11.3507-3513.1991

Malatesta, 1992, EGTA inhibition of DNase activity in commercial lysostaphin preparations, Biotechniques, 12, 71

Murphy, 1992, The role of the C-terminal domain in collagenase and stromelysin specificity, J. biol. Chem., 267, 9612, 10.1016/S0021-9258(19)50134-X

Murphy, 1991, Matrix metalloproteinase degradation of elastin, type IV collagen, and proteoglycan, Biochem. J., 277, 277, 10.1042/bj2770277

Murphy, 1974, Elastase production by oral staphylococci, J. Dent. Res., 53, 832, 10.1177/00220345740530041101

Park, 1991, Binding of elastin to Staphylococcus aureus, J. biol. Chem., 266, 23,399, 10.1016/S0021-9258(18)54510-5

Partridge, 1962, Elastin, Adv. Protein Chem., 17, 227, 10.1016/S0065-3233(08)60055-8

Potempa, 1988, Degradation of elastin by a cysteine proteinase from Staphylococcus aureus, J. biol. Chem., 263, 2664, 10.1016/S0021-9258(18)69118-5

Recsei, 1987, Cloning, sequence, and expression of the lysostaphin gene from Staphylococcus simulans, 84, 1127

Schindler, 1964, Lysostaphin: a new bacteriolytic agent for the Staphylococcus, 51, 414

Schindler, 1965, Purification and properties of lysostaphin: a lytic agent for Staphylococcus aureus, Biochem. Biophys. Acta, 97, 242, 10.1016/0304-4165(65)90088-7

Senior, 1991, Human 92- and 72-kilodalton type IV collagenases are elastases, J. biol. Chem., 266, 7870, 10.1016/S0021-9258(20)89530-1

Shapiro, 1992, Molecular cloning, chromosomal localization, and bacterial expression of a murine macrophage metalloelastase, J. biol. Chem., 267, 4664, 10.1016/S0021-9258(18)42885-2

Sloot, 1992, Purification and characterization of elastase from Staphylococcus epidermidis, J. Med. Microbiol., 37, 201, 10.1099/00222615-37-3-201

Teufel, 1993, Characterization of an extracellular metalloprotease with elastase activity from Staphylococcus epidermidis, J. Bacteriol., 175, 4218, 10.1128/jb.175.13.4218-4224.1993

Trayer, 1970, Molecular properties of lysostaphin, a bacteriolytic agent specific for Staphylococcus aureus, J. biol. Chem., 245, 4842, 10.1016/S0021-9258(18)62869-8

Vallee, 1992, Active zinc binding sites of zinc metalloenzymes, Matrix, 51, 5

Zygmunt, 1972, Lysostaphin: model for a specific enzymatic approach to infectious disease, Prog. Drug Res., 16, 309